Recent

% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

  • thesnowcrow thesnowcrow Mar 1, 2013 2:41 PM Flag

    Facility woes....

     

    From the news pages:

    Pluristem appears to have a solid technology platform and a sizable market to capture, but the regulatory hurdles and clinical trials are still in early stages.

    Because of the high investment risk associated with the startup of the new manufacturing facility, I would not recommend a buy until investors have seen the facility fully validated and have seen more tangible evidence of growth potential from the company's investment in the facility. I would rate Pluristem as a "hold but watch closely," and recommend investors watch for more company developments before risking capital.

    This topic is deleted.
 
PSTI
1.33-0.01(-0.75%)Jun 30 4:00 PMEDT